Andrew Sandler
Director/Board Member bij DERMATA THERAPEUTICS, INC.
Vermogen: 621 $ op 31-03-2024
Profiel
Andrew S.
Sandler is an Independent Director at Dermata Therapeutics, Inc. He previously held positions as Director-Clinical Development at Seagen Inc. from 1999 to 2003, Chief Medical Officer at Spectrum Pharmaceuticals, Inc. from 2008 to 2010, Head-Global Medical Affairs Oncology Division at Berlex, Inc. in 2003, Chief Medical Officer & Executive Vice President at Dendreon Corp., Senior Vice President-Medical Affairs at Medivation LLC (California) from 2016 to 2017, VP & Head-Global Medical Affairs Oncology Division at Bayer HealthCare Pharmaceuticals, Inc. from 2006 to 2008, and Chief Medical Officer at Kiadis Pharma NV from 2017 to 2022.
He also served as Chief Medical Officer at Dendreon Pharmaceuticals, Inc. from 2010 to 2015 and Chief Medical Officer at Alpine Immune Sciences, Inc. from 2022 to 2023.
Dr. Sandler obtained his undergraduate degree from Rochester Christian University and his doctorate from Icahn School of Medicine at Mount Sinai in 1990.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-03-2024 | 1 511 ( 0.02% ) | 621 $ | 31-03-2024 |
Actieve functies van Andrew Sandler
| Bedrijven | Functie | Begin |
|---|---|---|
| DERMATA THERAPEUTICS, INC. | Director/Board Member | 01-08-2021 |
Eerdere bekende functies van Andrew Sandler
| Bedrijven | Functie | Einde |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 02-10-2023 |
| KIADIS PHARMA N.V. | Chief Tech/Sci/R&D Officer | 01-06-2022 |
| MEDIVATION INC | Chief Tech/Sci/R&D Officer | 01-06-2017 |
Dendreon Pharmaceuticals, Inc.
 Dendreon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Dendreon Pharmaceuticals, Inc. discovers, develops and commercializes novel products for the treatment of cancer. The company is headquartered in Olympia, WA. | Chief Tech/Sci/R&D Officer | 01-04-2015 |
| SPECTRUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Andrew Sandler
| Rochester Christian University | Undergraduate Degree |
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| DERMATA THERAPEUTICS, INC. | Health Technology |
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
Berlex, Inc.
 Berlex, Inc. Pharmaceuticals: MajorHealth Technology Berlex, Inc. manufactured pharmaceutical company. It developed novel diagnostics and therapeutics, which address unmet medical needs. It used to researches, develops, manufactures and markets ethical pharmaceuticals in five strategic areas such as female healthcare, diagnostic imaging, dermatology, oncology and therapeutics. The company was headquartered in Wayne, NJ | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Health Technology |
Kiadis Pharma NV
 Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Kiadis Pharma NV engages in pharmaceutical development of cell-based immunotherapy products in the field of diseases of the blood building system. Its lead product is the ATIR101. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Dendreon Pharmaceuticals, Inc.
Dendreon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Dendreon Pharmaceuticals, Inc. discovers, develops and commercializes novel products for the treatment of cancer. The company is headquartered in Olympia, WA. | Health Technology |
